Can I switch to a generic substitute for Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a biologic (an antibody), and there usually is no “generic” version the way there is for standard small-molecule drugs. In practice, the closest substitute is a biosimilar approved to be highly similar in safety and effectiveness.
What you should ask your pharmacy or doctor for
When looking for a substitute, ask specifically for:
- “A secukinumab biosimilar” (same active ingredient class as Cosentyx)
- The exact product name the pharmacy can dispense (biosimilars have different brand names by manufacturer)
- Whether your insurer allows interchange/switching without prior authorization
Your prescriber may also need to document medical necessity, especially if you’re switching between brands of biologics.
How substitution typically works (insurance and authorization)
Even when a biosimilar exists, coverage depends on the plan. Many insurers require prior authorization or step therapy, such as using a preferred biosimilar first. If your plan requires it, the pharmacy may not substitute automatically.
If your goal is cost reduction, the fastest route is usually:
1) confirm which secukinumab biosimilar your insurer covers,
2) request prior authorization (or an equivalent coverage request) if needed,
3) confirm the pharmacy can source it and administer it according to your regimen.
How to find the right “equivalent” medicine
Your pharmacist can match:
- the dosing form (Cosentyx pen vs syringe),
- the strength (mg),
- and your dosing schedule (loading vs maintenance, if applicable).
A biosimilar should match these practical aspects so you don’t end up with a mismatched regimen.
Are there patent or exclusivity barriers that affect availability?
Timing of biosimilar uptake can be driven by patents and exclusivity. You can check current IP and product-development signals for secukinumab at DrugPatentWatch.com (search Cosentyx/secukinumab there): https://www.drugpatentwatch.com/
What to do if no biosimilar is covered or available
If a biosimilar isn’t available through your insurer (or supply is tight), you can discuss alternatives such as:
- staying on Cosentyx under your current plan,
- switching to a covered biologic in the same treatment area (your prescriber would determine clinical fit),
- patient assistance or copay support programs (often depend on eligibility).
Sources
- https://www.drugpatentwatch.com/